Assessing the safety of magnetic resonance imaging in cardiac device carriers
- 89 Downloads
Patients with a pacemaker (PM) or an implanted cardiac defibrillator (ICD) have an estimated 50–75% likelihood of having a clinical indication for magnetic resonance imaging (MRI) over the lifetime of their device .
Serious adverse effects have been described in electronic cardiac device carriers, in particular, inappropriate sensing, triggering or activation of the device, electrical reset and reed switch malfunction that could cause serious arrhytmias .
The American Heart Association (AHA) affirms that presently MRI examination in conventional electronic cardiac device carriers is discouraged, and should be considered only where there are strong clinical indications in which the benefits clearly outweigh risks. The AHA also suggested the production of MRI-compatible electronic cardiac devices to resolve any compatibility issues . On the other hand, the more recent European Society of Cardiology (ESC) guidelines on cardiac pacing suggest that in patients with...
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- 2.The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 34:2281–2329CrossRefGoogle Scholar